Rumours are swirling of a bid for Orpea, the scandal-hit pan-European care group. According to the rumours, another large French care home group is preparing a bid for Orpea. We hear this from a UK advisory source who named the buyer.
French elderly care giant Korian has been dragged into the controversy surrounding the French nursing home sector. A lawyer is launching a group lawsuit against the company based on the experiences of some of the residents at its nursing homes. HBI speaks to financial analysts to find out what the potential long term impact on the sector might be of this, and the ongoing Orpea crisis.
In contrast to other European countries such as the UK, Ireland and Sweden, France is not currently seeing consolidation of its primary care sector by major corporate entities. HBI speaks to Thomas Breuvart, associate and investor in healthcare at French evergreen investment firm Creadev, to find out why.
Germany, France and Italy are Europe's largest for-profit laboratory services markets, with heavyweight groups like Sonic, Synlab, and Cerba having significant market shares. As the major players continue to make large and bolt-on acquisitions, just how consolidated are these markets.
The French government has opened an investigation into nursing home giant Orpea and the company has terminated its CEO. This comes after a tumultuous week for the company in which allegations of widespread malpractice in its French nursing homes were published and its share price halved. Could Orpea be vulnerable to a bid?
The share prices of Europe’s two nursing home giants, Orpea and Korian, both plummeted on Monday, after extracts from a book about Orpea containing allegations of malpractice were published in French newspaper Le Monde. Orpea, whose shares have halved in value, strongly rejects the allegations.
Clinisys claims to have created the world’s largest player in lab information management and lab order comms and results software with a three-way merger which creates a platform across diagnostics and environmental tests. So how does CEO, Michael Simpson, see software changing the sector over the next 3-5 years? And what does an independent consultant with many years experience in the field think about the sector and its growth?
Nursing homes were firmly in the spotlight for all the wrong reasons as the pandemic hit at the start of 2020. Mortality rates were high, morale was low, and huge reputational damage was done. Two years on, HBI speaks to three European operators to find out how the market is recovering.
The big diagnostic lab groups are on a frantic M&A drive to capture capacity in genetic testing. The deals reflect the hunger for specialist genetic doctors, biologists and counsellors in a manpower intensive field which is seeing explosive growth. We look at recent deals and name the new competitors who are entering the market.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.